Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.70 Analyst target: $24.17 Upside: 260.75%
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.